NCT00503776 2017-06-20
Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia
Vanderbilt-Ingram Cancer Center
Phase 2 Terminated
Vanderbilt-Ingram Cancer Center
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Washington University School of Medicine
University of Arizona